Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized antibodies that target HM1.24

Optimized antibodies that target HM1.24

US Patent 9040042 · Granted May 26, 2015

Estimated economic value: $4,344,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
Anti-human C5 antibodies2025
Anti-human C5 antibodies2025
CTLA4-Ig immunoadhesins2025
CTLA4-Ig immunoadhesins2025
Heterodimeric human IgG1 polypeptides with isoelectric point modifications2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025